Your browser doesn't support javascript.
loading
A Novel CCM2 Gene Mutation Associated with Familial Cerebral Cavernous Malformation.
Huang, Wen-Qing; Lu, Cong-Xia; Zhang, Ya; Yi, Ke-Hui; Cai, Liang-Liang; Li, Ming-Li; Wang, Han; Lin, Qing; Tzeng, Chi-Meng.
Afiliación
  • Huang WQ; Translational Medicine Research Center, School of Pharmaceutical Sciences, Xiamen UniversityXiamen, China; Key Laboratory for Cancer T-Cell Theranostics and Clinical TranslationXiamen, China.
  • Lu CX; Department of Neurology, The First Affiliated Hospital of Xiamen University Xiamen, China.
  • Zhang Y; Translational Medicine Research Center, School of Pharmaceutical Sciences, Xiamen UniversityXiamen, China; Key Laboratory for Cancer T-Cell Theranostics and Clinical TranslationXiamen, China.
  • Yi KH; Department of Neurology, The First Affiliated Hospital of Xiamen UniversityXiamen, China; The First Clinical College of Fujian Medical UniversityFuzhou, China.
  • Cai LL; Translational Medicine Research Center, School of Pharmaceutical Sciences, Xiamen UniversityXiamen, China; Key Laboratory for Cancer T-Cell Theranostics and Clinical TranslationXiamen, China.
  • Li ML; Translational Medicine Research Center, School of Pharmaceutical Sciences, Xiamen UniversityXiamen, China; Key Laboratory for Cancer T-Cell Theranostics and Clinical TranslationXiamen, China.
  • Wang H; Translational Medicine Research Center, School of Pharmaceutical Sciences, Xiamen UniversityXiamen, China; Key Laboratory for Cancer T-Cell Theranostics and Clinical TranslationXiamen, China.
  • Lin Q; Translational Medicine Research Center, School of Pharmaceutical Sciences, Xiamen UniversityXiamen, China; Department of Neurology, The First Affiliated Hospital of Xiamen UniversityXiamen, China.
  • Tzeng CM; Translational Medicine Research Center, School of Pharmaceutical Sciences, Xiamen UniversityXiamen, China; Key Laboratory for Cancer T-Cell Theranostics and Clinical TranslationXiamen, China; INNOVA Cell: TDx/Clinics and TRANSLATE Health GroupYangzhou, China.
Front Aging Neurosci ; 8: 220, 2016.
Article en En | MEDLINE | ID: mdl-27708576
ABSTRACT

Background:

Cerebral cavernous malformations (CCMs) are common vascular malformations that predominantly arise in the central nervous system and are mainly characterized by enlarged vascular cavities without intervening brain parenchyma. Familial CCMs (FCCMs) is inherited in an autosomal dominant pattern with incomplete penetrance and variable symptoms.

Methods:

Mutations of three pathogenic genes, CCM1, CCM2, and CCM3, were investigated by direct DNA sequencing in a Chinese family with multiple CCM lesions.

Results:

Four heterozygous variants in the CCM2 gene, including one deletion (c.95delC), a missense mutation (c.358G>A, p.V120I), one silent mutation (c.915G>A, p.T305T), and a substitution (c. *1452 T>C), were identified in the subjects with multiple CCM lesions, but not in a healthy sibling. Among these variants, the c.95delC deletion is a novel mutation which is expected to cause a premature termination codon. It is predicted to produce a truncated CCM2 protein lacking the PTB and C-terminal domains, thus disrupting the molecular functions of CCM2.

Conclusions:

The novel truncating mutation in the CCM2 gene, c.95delC, may be responsible for multiple CCM lesions in a part of FCCM. In addition, it may represent a potential genetic biomarker for early diagnosis of FCCM.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Front Aging Neurosci Año: 2016 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Front Aging Neurosci Año: 2016 Tipo del documento: Article País de afiliación: China